Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome.
J Allergy Clin Immunol Pract. 2022 Jan;10(1):349-351.e1. doi: 10.1016/j.jaip.2021.08.042. Epub 2021 Sep 16.
J Allergy Clin Immunol Pract. 2022.
PMID: 34536614
No abstract available.